Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Aeglea Biorapeutics

Paltalk And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

The Dow Jones tumbled by over 500 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment…

Benzinga · Aug 26, 2022

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · Aug 22, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga · Aug 18, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022

Benzinga · Jun 3, 2022

Aeglea BioTherapeutics Earnings Perspective: Return On Capital Employed

Aeglea BioTherapeutics (NASDAQ:AGLE) brought in sales totaling $1.36 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 19.51%, resulting in a loss of $24.44 million.

Benzinga · May 26, 2022

Aeglea BioTherapeutics: Q1 Earnings Insights

Aeglea BioTherapeutics (NASDAQ:AGLE) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 5, 2022

Aeglea BioTherapeutics's Return On Capital Employed Overview

Benzinga Pro data, Aeglea BioTherapeutics (NASDAQ:AGLE) reported Q4 sales of $3.64 million. Earnings fell to a loss of $20.45 million, resulting in a 0.68% decrease from last quarter.

Benzinga · Mar 10, 2022

Read news from The Economist, FT, and more,
with one subscription

Coverage From

Benzinga

Organisations

Huntington Bancshares

50 stories

Keefe Bruyette & Woods

Martin Marietta Materials

31 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.